Detalhe da pesquisa
1.
Salivary gland-type cancers: cross-organ demographics of a rare cancer.
Int J Clin Oncol
; 2024 Mar 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38492066
2.
Efficacy and Safety of Electrohydraulic Lithotripsy Using Peroral Cholangioscopy under Endoscopic Retrograde Cholangiopancreatography Guidance in Older Adults: A Single-Center Retrospective Study.
Medicina (Kaunas)
; 59(4)2023 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37109751
3.
Neoadjuvant S-1 With Concurrent Radiotherapy Followed by Surgery for Borderline Resectable Pancreatic Cancer: A Phase II Open-label Multicenter Prospective Trial (JASPAC05).
Ann Surg
; 276(5): e510-e517, 2022 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33065644
4.
Diagnostic value of peroral cholangioscopy in addition to computed tomography for indeterminate biliary strictures.
Surg Endosc
; 36(5): 3408-3417, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34370123
5.
Liver cirrhosis is a risk factor for poor prognosis of acute cholangitis caused by choledocholithiasis.
Ann Hepatol
; 27(3): 100696, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35257932
6.
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.
Br J Cancer
; 124(8): 1388-1397, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33531690
7.
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434).
Invest New Drugs
; 39(1): 152-162, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32564277
8.
Analysis of circulating cell-free DNA after endoscopic ultrasound-guided fine needle aspiration in pancreatic ductal adenocarcinoma.
Pancreatology
; 2021 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33865724
9.
Current status of medical oncology in Japan and changes over the most recent 7-year period: results of a questionnaire sent to designated cancer care hospitals.
Jpn J Clin Oncol
; 51(11): 1622-1627, 2021 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34414432
10.
Diverse transitions in diabetes status during the clinical course of patients with resectable pancreatic cancer.
Jpn J Clin Oncol
; 50(12): 1403-1411, 2020 Dec 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32761096
11.
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(2): 282-296, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30665869
12.
Alternate Endpoints for Phase II Trials in Advanced Neuroendocrine Tumors.
Oncologist
; 24(1): 47-53, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30072388
13.
Phase I study of resminostat, an HDAC inhibitor, combined with S-1 in patients with pre-treated biliary tract or pancreatic cancer.
Invest New Drugs
; 37(1): 109-117, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29995287
14.
Characterization of low active ghrelin ratio in patients with advanced pancreatic cancer.
Support Care Cancer
; 26(11): 3811-3817, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-29777378
15.
Neural Invasion Spreads Macrophage-Related Allodynia via Neural Root in Pancreatic Cancer.
Anesth Analg
; 126(5): 1729-1738, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29570153
16.
Transarterial (Chemo)Embolization for Liver Metastases in Patients with Neuroendocrine Tumors.
Oncology
; 92(6): 353-359, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28329738
17.
Phase I trial of GBS-01 for advanced pancreatic cancer refractory to gemcitabine.
Cancer Sci
; 107(12): 1818-1824, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27685612
18.
Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.
Jpn J Clin Oncol
; 46(2): 132-7, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26685318
19.
Screening rate for hepatitis B virus infection in patients undergoing chemotherapy in Japan.
Int J Clin Oncol
; 21(6): 1162-1166, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27260010
20.
Prognostic factors in patients with hepatocellular carcinoma refractory or intolerant to sorafenib.
Oncology
; 88(4): 241-6, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25503567